Skip to content
lifestyle.lincolnlabs.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Biodexa Pharmaceuticals PLC
Postponement and Re-scheduling of Annual General Meeting
June 17, 2026
Biodexa issues letter to Shareholders
May 14, 2026
Preliminary Results for the Year Ended 31 December 2025
March 30, 2026
Biodexa Licenses Phase 1 Ready Drug Candidate from Otsuka for Rare Stomach Cancer
February 19, 2026
←
Previous Page
1
2